Skip to main content

Month: August 2020

Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020

NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today reported operational highlights and financial results for the fourth quarter and full-year ended June 30, 2020 (FY2020).Mesoblast Chief Executive Dr Silviu Itescu stated: “We are very pleased to report the significant corporate progress made by the Company over the last financial year. The most notable achievement was the successful FDA Advisory Committee meeting held this month which resulted in an overwhelmingly positive vote in favor of the efficacy of our lead product candidate remestemcel-L (RYONCIL™) for children with steroid-refractory acute graft versus host disease (aGVHD). We are working closely with the FDA ahead of next month’s approval action date and are well prepared for a potential US launch during Q4 2020, with inventory...

Continue reading

Avante Logixx Inc. Announces First Quarter Financial Results for the Three-Month Period Ended June 30, 2020

Not for distribution to U.S. news wire services or for dissemination in the United StatesTORONTO, Aug. 26, 2020 (GLOBE NEWSWIRE) — Avante Logixx Inc. (TSX.V: XX) (OTC: ALXXF) (“Avante” or the “Company”) is pleased to announce its results for the three-month period ended June 30, 2020 (all amounts in thousands of Canadian dollars, unless otherwise indicated).RESULTS FOR THE THREE-MONTH PERIOD ENDED JUNE 30, 2020“During our first quarter ended June 30, 2020, we continued to execute on our strategy and strengthen Avante through organic growth and integration activities,” said Craig Campbell, CEO and Director of Avante.  “On a sequential basis compared to Q4 of our prior fiscal year, this quarter’s revenue was higher, gross profit margin percentages were stronger, and we delivered lower direct operating expenses.  These factors combined...

Continue reading

Secureworks to Report Second Quarter Fiscal 2021 Financial Results on Sept. 9, 2020

ATLANTA, Aug. 26, 2020 (GLOBE NEWSWIRE) — Secureworks (NASDAQ: SCWX) today announced that it plans to release its second quarter fiscal 2021 financial results Wednesday, Sept. 9, 2020, before the open of regular U.S. stock market trading hours.Secureworks will host a conference call that day to review the results at 8:00 a.m. ET. A live audio webcast of the conference call will be accessible on the company’s website at http://investors.secureworks.com. The webcast will be archived at the same location for one year.About SecureworksSecureworks® (NASDAQ: SCWX), a global cybersecurity leader, enables our customers and partners to outpace and outmaneuver adversaries with more precision, so they can rapidly adapt and respond to market forces to meet their business needs. With a unique combination of cloud-native, SaaS security platform...

Continue reading

Team Tankers International Ltd. : 2nd Quarter 2020 Results

August 27, 2020Team Tankers International Ltd. Announces 2nd Quarter 2020 Results 2nd Quarter 2020 resultsTeam Tankers International Ltd. (OSE: TEAM) reported EBITDA for the 2nd quarter of $21.7 million, compared with $16.5 million in the 1st quarter of 2020 (Q2’19: $11.8 million).  Net loss in the 2nd quarter of 2020 was $2.4 million, compared with a net income of $1.4 million in the 1st quarter of 2020 (Q2’19 net loss: $17.4 million). The average time charter equivalent rate for the fleet was $14,667 per day this quarter, compared with $13,812 per day in the previous quarter. Team’s CEO, Hans Feringa, commented “We executed the strategic commercial cooperation with Maersk Tankers and commenced the joint venture with V.Group for technical management, building commercial and operational scale for our tanker fleet. The two...

Continue reading

Genmab Announces Late-Breaking Oral Presentation of Phase 2 innovaTV 204 Study at the ESMO Virtual Congress 2020

Media ReleaseInnovaTV 204 study evaluated tisotumab vedotin in recurrent or metastatic cervical cancerData from the study selected as a late-breaking abstract at ESMO, oral presentation is at 17:04 CEST on Sep 21, 2020                                                                          Genmab A/S (Nasdaq: GMAB) announced today that results from the phase 2 innovaTV 204 study evaluating tisotumab vedotin in patients with recurrent or metastatic cervical cancer will be presented as a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) Virtual Congress 2020. The abstract is scheduled to be available on Sep 19, 2020 and will be published online via the ESMO website.  “We are very pleased that the innovaTV 204 study is selected as a late-breaking oral presentation at ESMO,” said Jan van de Winkel, Ph.D.,...

Continue reading

Teladoc Health Is Providing Free Virtual Health Care Services to Those Impacted by Western Wildfires

PURCHASE, NY, Aug. 26, 2020 (GLOBE NEWSWIRE) — Teladoc Health (NYSE: TDOC), the global leader in virtual care, is providing free, 24/7 general medical telehealth visits to residents, first responders and others directly impacted by the western fires currently devastating many parts of California, Oregon and Colorado. Individuals who have been displaced or who cannot access medical care as a result of the wildfires can seek treatment from a board-certified, state licensed physician for any non-emergency illness by calling Teladoc directly at 855-225-5032.With the COVID-19 pandemic presenting an additional health risk, its vital that those impacted know they have immediate access to care in their time of need.“Natural disasters strain communities and health care delivery. This wildfire season is more complicated with an active pandemic...

Continue reading

Acceleware Ltd. Reports Second Quarter 2020 Financial and Operating Results

CALGARY, Alberta, Aug. 26, 2020 (GLOBE NEWSWIRE) — Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), an innovator and leading developer of transformative clean-tech energy technologies, today announced its financial and operating results for the three and six months ended June 30, 2020 (all figures are in Canadian dollars unless otherwise noted). Acceleware’s second quarter results reflect contributions from the Company’s two business units, comprised of radio frequency heating technology (“RF Heating”) which supports cost-effective and environmentally friendly extraction of heavy oil and bitumen through its proprietary RF XL Heating technology, along with high-performance scientific computing applications (“HPC”). This news release should be read in conjunction with the Company’s unaudited interim condensed financial...

Continue reading

Platinex Inc. Completes Non-Brokered Private Placement With a Lead Order From Palisades Goldcorp

TORONTO, Aug. 26, 2020 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (the “Company” or “Platinex“) is pleased to announce that it has completed its previously announced non-brokered private placement (the “Private Placement“), issuing a total of 13,722,000 units (“Units“) for gross proceeds of $960,540 with a lead order from Palisades Goldcorp. Each Unit consists of one common share (a “Common Share“) of the Company and one common share purchase warrant (a “Warrant“) of the Company. Each Warrant entitles the holder to acquire one additional Common Share at an exercise price of $0.10 for a period of 36 months from the date of issuance.The Company intends to use the proceeds of the Private Placement to incur exploration expenses on its Shining Tree property and...

Continue reading

UPDATE – Mohawk Group Announces Closing of $23.5 Million Underwritten Public Offering of Common Stock and Closing of the Acquisition of Truweo

NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) — Mohawk Group Holdings, Inc. (NASDAQ: MWK) (“Mohawk”), the technology-enabled consumer products company, today announced the closing of its previously announced underwritten public offering of 3,357,140 shares of its common stock at a public offering price of $7.00 per share, before deducting underwriting discounts and commissions and estimated offering expenses payable by Mohawk.  The net proceeds to Mohawk from this offering are expected to be approximately $20.6 million, after deducting underwriting discounts and commissions and other estimated offering expenses.Mohawk also announced the closing of its previously announced acquisition of assets of Truweo, a leading ecommerce brand in the health and personal wellness category. At the closing of the acquisition, Mohawk utilized $13.9 million...

Continue reading

Cocrystal Pharma Announces $10.0 Million Bought Deal Offering

BOTHELL, WA, Aug. 26, 2020 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced today that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 9,523,810 shares of common stock of the Company, at a price to the public of $1.05 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about August 31, 2020, subject to satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.The Company also has granted to the underwriter a 30-day option to purchase up to an...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.